Loading...
Market
What will Summit Therapeutics' next quarterly revenue report show?
2
Resolution / Starting Odds
Below $100 million • 25%
$100-$149.99 million • 25%
$150-$199.99 million • 25%
$200 million or above • 25%
Summit Therapeutics' official quarterly earnings report or major financial news outlets
Story
Summit Therapeutics Raises $235M in Private Placement, Market Cap at $18.7B
Sep 12, 2024, 12:44 PM
Summit Therapeutics has raised $235 million through a private placement, issuing 10.35 million shares at $22.70 per share. Of the total amount, $79 million was raised by insiders, with the remaining $156 million coming from multiple leading biopharma institutional investors. The company's market capitalization is approximately $18.7 billion. This fundraising effort follows the company's strong pricing and substantial insider participation, reflecting confidence in its future prospects. The raise was also influenced by significant lung cancer data.
View original story
Similar markets
Less than $500 million • 25%
$500 million to $1 billion • 25%
$1 billion to $1.5 billion • 25%
More than $1.5 billion • 25%
Yes • 50%
No • 50%
Below $10 million • 25%
$10 million to $20 million • 25%
$20 million to $30 million • 25%
Above $30 million • 25%
Yes • 50%
No • 50%
Less than $300M • 33%
$300M - $500M • 33%
More than $500M • 33%
More than 20% increase • 25%
10%-20% increase • 25%
0%-10% increase • 25%
Decrease • 25%
Below $2.4 billion • 25%
$2.4 billion to $2.5 billion • 25%
$2.5 billion to $2.6 billion • 25%
Above $2.6 billion • 25%
